AeroLeads people directory · profile

Kenneth Low Email & Phone Number

Global Head of Media R and D at Lonza
Location: Rockville, Maryland, United States 8 work roles 5 schools
1 work email found @lonza.com LinkedIn matched
✓ Verified May 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email k****@lonza.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Global Head of Media R and D
Location
Rockville, Maryland, United States
Company size

Who is Kenneth Low? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Kenneth Low is listed as Global Head of Media R and D at Lonza, a company with 18167 employees, based in Rockville, Maryland, United States. AeroLeads shows a work email signal at lonza.com and a matched LinkedIn profile for Kenneth Low.

Kenneth Low previously worked as Global Head of Media R&D at Lonza and Senior Director, Project Management Office at Leidos Biomedical Research, Inc.. Kenneth Low holds Associate Research Scientist (Non-Tenure Track Faculty), Oncology, Cancer Biology, Cellular Transformation, Human Tumor Viruses, Kshv/Hhv-8 from Columbia University Vagelos College Of Physicians And Surgeons.

Company email context

Email format at Lonza

This section adds company-level context without repeating Kenneth Low's masked contact details.

{first}.{last}@lonza.com
89% confidence

AeroLeads found 1 current-domain work email signal for Kenneth Low. Compare company email patterns before reaching out.

Profile bio

About Kenneth Low

Experienced Research & Development Executive in* Drug Discovery/Preclinical Development (Velafermin/CG53135 & CR002 PDGF mAb)* ADME-Tox Services (CYP Inhibition/Induction/Phenotyping/Pathway Analysis, Metabolic Stability, Metabolite Profiling/Identification, Cytotoxicity, Protein/Plasma Binding, Caco-2-based Transport, Dermal Absorption/Metabolism)* Biochemical & Cell-Based Assay Development (Transcription Factors, Kinases, GPCRs & Proteases)* High-Throughput & High-Content Screening (Reporter Assays, ß-Lactamase, Luciferase, FRET, TRF & SPA Assays)* Target Identification & Validation (Oncology, Obesity, Diabetes, Inflammation, Neurodegenration & Virology)* Product Development (Fluorescent Probes, Enzymes, Protein Expression, Primary Cells, Core & Specialty Media, Growth Factors & Supplements, 3D Matrices)* Project & Program Management (Phase-Gated Product Development Process)* Portfolio Management & Strategic Planning (at Business Unit and Divisional Levels)Seeks challenging professional opportunties at the executive leadership level.Specialties: Drug Discovery: HTS/HCS, Biochemical/Cell-Based Assay Development, Target Identification/ValidationPreclinical Development: ADME-Tox for pre-IND and NDA filings, Biomarker/Bioanalytical Assay Development, Protein & mAb TherapeuticsProduct Development: Probes, Enzymes, Protein Expression, Cells, Media & 3D Matrices, Phase-Gated Product Development ProcessExecutive Leadership Expertise: Portfolio Management/Strategic Planning, Financial Planning/Performance Metrics

Listed skills include Drug Discovery, Drug Development, Project Portfolio Management, Clinical Development, and 18 others.

Current workplace

Kenneth Low's current company

Company context helps verify the profile and gives searchers a useful next step.

Lonza
Lonza
Global Head of Media R and D
Rockville, MD, US
Website
Employees
18167
AeroLeads page
8 roles

Kenneth Low work experience

A career timeline built from the work history available for this profile.

Global Head Of Media R And D

Rockville, MD, US

Global Head Of Media R&D

Current

Basel, CH

  • Leading media development and optimization needs for different business units at Lonza Pharma Biotech & Nutrition including
  • Bioscience
  • Cell & Gene Therapy
  • Mammalian & Microbial Development & Manufacturing
  • Consumer Health & Nutrition
Aug 2019 - Present

Senior Director, Project Management Office

Drug Discovery and Development Project Management for the National Cancer Institute Experimental Therapeutics (NExT) Program under the Division of Cancer Treatment and Diagnosis (DCTD) and the Center for Cancer Research (CCR)

May 2010 - Aug 2019

Director, Development Services

Celsis In Vitro Technologies

ADME-Tox Services

Nov 2008 - Apr 2010

Director R&D, Cell Systems Division

Waltham, MA, US

Cell Biology, Molecular Biology, Cell Culture & Media Development, Product & Services Development, Program & Portfolio Management, Strategic Planning & Innovation

Jan 2004 - Nov 2008

Group Leader, Drug Discovery & Preclinical Development

US

Target Validation, Functional Cell-Based Assay Development, High-Throughput Screening (HTS), High-Content Screening (HCS), Oncology, Cancer Biology, Obesity, Diabetes, Inflammation and Neurodegenerative Disorders, Bioanalytics & Biomarkers, Signal Pathway Mapping, Gene Overexpression & Gene Silencing (RNAi), Biotherapeutics, Monoclonal Antibody-Based (mAb).

Jun 2001 - Dec 2003

Senior Research Investigator, Drug Discovery

Lawrence Township, NJ, US

Drug Discovery, Target Validation, Biochemical & Cell-Based Assay Development, High-Throughput Screening (HTS), Ultra High-Throughput Screening (uHTS), High-Content Screening (HCS), Gene Reporter Assays (ß-lactamase/Luciferase), Kinase Assays, G-Protein Coupled Receptor (GPCR) Assays, Protease Assays, Oncology, Virology, Metabolic & Cardiovascular.

Jun 1999 - Jun 2001

Product Manager

Ipswich, MA, US

Product Development, Manufacturing & Operations, Vent™ & Deep Vent™ thermostable DNA polymerases, IMPACT™ Protein Expression System

Nov 1994 - Jan 1997
Team & coworkers

Colleagues at Lonza

Other employees you can reach at lonza.com. View company contacts for 18167 employees →

5 education records

Kenneth Low education

Associate Research Scientist (Non-Tenure Track Faculty), Oncology, Cancer Biology, Cellular Transformation, Human Tumor Viruses, Kshv/Hhv-8

Columbia University Vagelos College Of Physicians And Surgeons

Post-Doctoral Fellow, Neurobiology, Oncology, Transcription, Cell Signaling, Human Tumor Viruses, Htlv-1

Harvard Medical School

Phd, Biochemistry & Molecular Biology

University Of Miami Miller School Of Medicine

Msc, Biochemistry & Molecular Biology

National University Of Singapore

Bsc, Biochemistry & Human Biology

University Of Guelph
FAQ

Frequently asked questions about Kenneth Low

Quick answers generated from the profile data available on this page.

What company does Kenneth Low work for?

Kenneth Low works for Lonza.

What is Kenneth Low's role at Lonza?

Kenneth Low is listed as Global Head of Media R and D at Lonza.

What is Kenneth Low's email address?

AeroLeads has found 1 work email signal at @lonza.com for Kenneth Low at Lonza.

Where is Kenneth Low based?

Kenneth Low is based in Rockville, Maryland, United States while working with Lonza.

What companies has Kenneth Low worked for?

Kenneth Low has worked for Lonza, Leidos Biomedical Research, Inc., Celsis In Vitro Technologies, Life Technologies (Invitrogen/Gibco), and Curagen Corporation.

Who are Kenneth Low's colleagues at Lonza?

Kenneth Low's colleagues at Lonza include Joshua Doda, Kavika Peiris, Cáit Burns, Katherine Stout, and Kathryn Inman.

How can I contact Kenneth Low?

You can use AeroLeads to view verified contact signals for Kenneth Low at Lonza, including work email, phone, and LinkedIn data when available.

What schools did Kenneth Low attend?

Kenneth Low holds Associate Research Scientist (Non-Tenure Track Faculty), Oncology, Cancer Biology, Cellular Transformation, Human Tumor Viruses, Kshv/Hhv-8 from Columbia University Vagelos College Of Physicians And Surgeons.

What skills is Kenneth Low known for?

Kenneth Low is listed with skills including Drug Discovery, Drug Development, Project Portfolio Management, Clinical Development, Cell, Protein Expression, Product Development, and Leadership.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.